Royalty and Commercial Payment Purchase Agreements - Affitech (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Oct. 06, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Agreements | ||||
| Long-term royalty and commercial payment receivables | $ 69,075 | $ 34,575 | $ 34,375 | |
| Contingent consideration under RPAs and CPPAs | 8,075 | 75 | ||
| Impairment of long-term royalty receivable | 0 | $ 0 | ||
| Affitech | Commercial payment purchase agreement | ||||
| Agreements | ||||
| Upfront payment | $ 6,000 | |||
| Payments eligible to receive (as a percent) | 0.50% | |||
| Commercial payment receivable term | 10 years | |||
| Maximum additional payments upon achievement of regulatory and sales milestones | $ 20,000 | |||
| Maximum payable on regulatory milestone | 8,000 | |||
| Maximum payable on sales milestone | 12,000 | |||
| Long-term royalty and commercial payment receivables | 14,000 | |||
| Contingent consideration under RPAs and CPPAs | $ 8,000 | |||
| Impairment of long-term royalty receivable | $ 0 | |||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Term of commercial payment receivable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Payments entity eligible to receive as a percentage of net sales. No definition available.
|
| X | ||||||||||
- Definition Contingent consideration under purchase agreements. May include royalty purchase agreements and commercial payment purchase agreements. No definition available.
|
| X | ||||||||||
- Definition Maximum eligible milestone payments receivable upon achievement of sales and/or regulatory milestones. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long term royalty receivable assets. No definition available.
|
| X | ||||||||||
- Definition Long-term royalty and commercial rights receivables, non current. No definition available.
|
| X | ||||||||||
- Definition Maximum amount payable on regulatory milestone. No definition available.
|
| X | ||||||||||
- Definition Maximum amount payable on sales milestone. No definition available.
|
| X | ||||||||||
- Definition The cash outflow for initial payment under agreement. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|